VivoSeq
Other

Preterm Birth

1

Pipeline Programs↗

8

Active Trials↗

3

Companies Involved↗

Preterm Birth is an early-stage landscape with 1 program across 3 companies. The most active players are Pfizer, Juniper Pharmaceuticals, Inc., AMAG Pharmaceuticals, Inc..

Intelligence

Pipeline Metrics

Competitive Density

27/100

Pipeline Velocity

22/100

Mech. Concentration

100/100

Completion Rate

78/100

Attrition Rate

15/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Pfizer logo

Pfizer

1 program

Phase 2J

Juniper Pharmaceuticals, Inc.

0 programs

PreclinicalA

AMAG Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

Sulfasalazine

Pfizer

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

34

clinical trials

Completed18 · 53%
Terminated4 · 12%
Not yet recruiting4 · 12%
Unknown status3 · 9%
Recruiting3 · 9%
Active, not recruiting1 · 3%
Other1 · 3%

Clinical Trials

Trial Activity

34 trials

Development and Clinical Evaluation of an Innovative Medical Device to Predict Preterm Birth (PrediMAP)
Recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT05586334·3,600 enrolled
The Effect of Sulfasalazine on CRH Levels in Pregnant Women With a History of Pre-Term Birth: A Randomized Controlled Trial
Recruiting·RRutgers, The State University of New Jersey·Phase 2·NCT05703425·50 enrolled
Does AI Make Clinicians More Appropriately Confident? A Randomized Study in Preterm Birth Prediction
Recruiting·—·Preclinical·NCT07402668·125 enrolled
Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth
Active, not recruiting·TTampere University·Phase 3·NCT00131235·1,320 enrolled
Effectiveness of Targeted Cervical Length Screening Guided by a Preterm Birth Risk Scoring System in Reducing the Rate of Preterm Birth
Not yet recruiting·—·N/A·NCT07415070·1,000 enrolled
Deimplementation of Activity Restriction for Preterm Birth Prevention in High-Risk Pregnancy (DE-RESTRICT): A Pilot Single-Arm Hybrid Effectiveness-Deimplementation Trial
Not yet recruiting·UUniversity of Pennsylvania·Preclinical·NCT07698483·237 enrolled
Periodontal Disease and Small Vulnerable Newborns in Rural Nepal: A Community-based Randomized Trial
Not yet recruiting·JJohns Hopkins Bloomberg School of Public Health·Phase 3·NCT07553286·2,280 enrolled
The Impact of a Culturally-based Live Music Intervention on the Metabolites and Metabolic Pathways Associated With Chronic Stress and the Risk of Pre-term Birth in Black Women
Not yet recruiting·CColumbia University·Preclinical·NCT05945264·142 enrolled
The Use of Progesterone to Reduce Preterm Birth
Completed·UUniversity of Mississippi Medical Center·N/A·NCT00830765·144 enrolled
Assessment of DHA On Reducing Early Preterm Birth
Completed·UUniversity of Kansas Medical Center·Phase 3·NCT02626299·1,100 enrolled
Clindamycin to Reduce Preterm Birth in a Low Resource Setting
Completed·CChristiana Care Health Services·Phase 4·NCT01800825·1,726 enrolled
17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies
Completed·OObstetrix Medical Group·Phase 2/3·NCT00163020·321 enrolled
Comparative Study Between Vaginal Progesterone Alone or Combined With Aspirin in Prevention of Recurrent Preterm Birth
Completed·MMenoufia University·Phase 4·NCT05319834·256 enrolled
Vaginal Progesterone to Reduce the Risk of Another Preterm Birth
Completed·JJuniper Pharmaceuticals, Inc.·Phase 3·NCT00086177·636 enrolled
Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)
Completed·TThe George Washington University Biostatistics Center·Phase 3·NCT00099164·795 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)